Matthias Alder

Insider Reports History

Entity
Individual
Location
C/O Micromet, Inc., 6707 Democracy Blvd., Ste. 505, Bethesda, MD
Signature
/s/ Matthias Alder
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthias Alder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Executive Officer, Director Common Stock 21.1K $85.8K $4.06 Mar 26, 2024 Direct
Gain Therapeutics, Inc. Chief Executive Officer, Director Restricted Stock Units 6.38K $24.6K $3.86 Mar 26, 2024 Direct
Gain Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 370K Mar 21, 2024 Direct

Insider Reports Filed by Matthias Alder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Mar 26, 2024 7 -$24.7K 4 Mar 28, 2024 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Mar 21, 2024 1 $0 4 Mar 25, 2024 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Dec 20, 2023 3 -$507 4 Dec 22, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Dec 7, 2023 1 -$4.55K 4 Dec 14, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Oct 1, 2023 2 $0 4 Oct 3, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Sep 20, 2023 2 $0 4 Sep 22, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Jul 1, 2023 2 $0 4 Jul 5, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Mar 23, 2023 2 $0 4 Mar 27, 2023 Chief Executive Officer, Director
GANX Gain Therapeutics, Inc. Sep 20, 2022 2 $0 4 Sep 22, 2022 Chief Operating Officer, Director
GANX Gain Therapeutics, Inc. Jul 15, 2022 2 $0 4 Jul 19, 2022 Chief Operating Officer
GANX Gain Therapeutics, Inc. Dec 23, 2021 1 $1.17M 4 Dec 28, 2021 CHIEF OPERATING OFFICER
GANX Gain Therapeutics, Inc. Dec 23, 2021 0 $0 3 Dec 28, 2021 CHIEF OPERATING OFFICER